Inherited focal segmental glomerulosclerosis
MONDO:0005363An instance of focal segmental glomerulosclerosis that is caused by an inherited genomic modification in an individual.
5 clinical trials for this condition and its sub-types, 1 tagged with Inherited focal segmental glomerulosclerosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited focal segmental glomerulosclerosis
-
HIV-associated nephropathy 2 trials
-
Focal segmental glomerulosclerosis 1 0 trials
-
Focal segmental glomerulosclerosis 5 0 trials
-
Focal segmental glomerulosclerosis 6 0 trials
-
Focal segmental glomerulosclerosis 7 0 trials
-
Focal segmental glomerulosclerosis 8 0 trials
-
Focal segmental glomerulosclerosis 9 0 trials
-
New kidney drug shows promise in FSGS trial
Disease control CompletedThis Phase 3 trial tested whether sparsentan, a drug that blocks two pathways involved in kidney damage, can better protect kidney function than the standard treatment irbesartan in people with focal segmental glomerulosclerosis (FSGS). The study enrolled 371 adults and children …
Phase 3 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Gene hunt for kidney disease FSGS aims to explain racial disparities
Knowledge-focused CompletedThis study searched for genetic factors that may cause focal segmental glomerulosclerosis (FSGS), a kidney disease that can lead to kidney failure. Researchers compared DNA from 616 people, including African-Americans with FSGS, African-Americans with HIV but no FSGS, and non-Afr…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC